At a glance
- Originator Roche
- Class Antivirals
- Mechanism of Action RNA-directed DNA polymerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued HIV-1 infections
Most Recent Events
- 13 Feb 2001 Profile reviewed but no significant changes made
- 05 Aug 1998 No-Development-Reported for HIV-1 infections in Germany (Unknown route)